Back to Search
REBECCA KLISOVIC, M.D.
M.D.
Medical Oncology Physician
NPI: 1417962945IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology (Internal Medicine) Physician
Internal Medicine — Hematology
Code: 207RH0000X
35079648(OH)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
78405(GA)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
OHIO STATE UNIVERSITY COLLEGE OF MEDICINE
Class of 1997
Research & Publications (15)
A LC-MS/MS method for the analysis of intracellular nucleoside triphosphate levels.
PMID 19291372·Pharm Res·2009
4-observational
Enzyme kinetics of GTI-2040, a phosphorothioate oligonucleotide targeting ribonucleotide reductase.
PMID 18653746·Drug Metab Dispos·2008
3-trial
Phase I study of GTI-2040, an antisense to ribonucleotide reductase, in combination with high-dose cytarabine in patients with acute myeloid leukemia.
PMID 18559610·Clin Cancer Res·2008
3-trial
Addition of infliximab to standard acute graft-versus-host disease prophylaxis following allogeneic peripheral blood cell transplantation.
PMID 18541197·Biol Blood Marrow Transplant·2008
3-trial
A phase I biological study of MG98, an oligodeoxynucleotide antisense to DNA methyltransferase 1, in patients with high-risk myelodysplasia and acute myeloid leukemia.
PMID 18413836·Clin Cancer Res·2008
3-trial
Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NF-kappaB-dependent DNA methyltransferase activity in acute myeloid leukemia.
PMID 18083845·Blood·2008
8-other
Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemia.
PMID 17679729·J Clin Oncol·2007
3-trial
Hyperglycemia in patients with acute myeloid leukemia is associated with increased hospital mortality.
PMID 17534900·Cancer·2007
8-other
Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
PMID 17389244·J Pharmacol Exp Ther·2007
8-other
Characterization of in vitro and in vivo hypomethylating effects of decitabine in acute myeloid leukemia by a rapid, specific and sensitive LC-MS/MS method.
PMID 17264127·Nucleic Acids Res·2007
4-observational
Quantification of valproic acid and its metabolite 2-propyl-4-pentenoic acid in human plasma using HPLC-MS/MS.
PMID 17147984·J Chromatogr B Analyt Technol Biomed Life Sci·2007
4-observational
Phase 1 clinical results with tandutinib (MLN518), a novel FLT3 antagonist, in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome: safety, pharmacokinetics, and pharmacodynamics.
PMID 16902153·Blood·2006
3-trial
Phase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: pharmacokinetics, pharmacodynamics, and clinical activity.
PMID 15824414·J Clin Oncol·2005
3-trial
The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy.
PMID 15774615·Blood·2005
8-other
A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia.
PMID 15466934·Blood·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1365 CLIFTON RD NE
ATLANTA, GA 30322 - Phone
- (404) 778-3932
Quick Facts
- NPI
- 1417962945
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 29
- Publications
- 15
Are you this provider?
Claim Your Profile